Related Experiment Video
Updated: Nov 2, 2025

A Comparative Study of Drug Delivery Methods Targeted to the Mouse Inner Ear: Bullostomy Versus Transtympanic Injection
Published on: March 8, 2017
Past and Future Biologics for Otologic Disorders
Steven A Gordon1, Richard K Gurgel1
1Otolaryngology-Head & Neck Surgery, University of Utah Health, 50 North Medical Drive 3C120 SOM, Salt Lake City, UT 84132, USA.
Biologic therapies offer new ways to manage hearing loss. This review covers growth factors, apoptosis inhibitors, monoclonal antibodies, and gene therapy for otology.
Area of Science:
- Otolaryngology
- Regenerative Medicine
- Molecular Biology
Background:
- Hearing loss is a growing global health concern.
- Current treatments for hearing loss are limited.
- Biologic therapies represent a promising new avenue for treatment.
Purpose of the Study:
- To review the current applications of biologic therapies in otology.
- To explore the potential future directions of these therapies.
- To familiarize clinicians with prospective biologic treatments for hearing loss.
Main Methods:
- Review of current literature on biologic therapies in otology.
- Categorization of therapies into growth factors, apoptosis inhibitors, monoclonal antibodies, and gene therapy.
- Analysis of existing and potential future applications.
Main Results:
- Biologic therapies, including growth factors, apoptosis inhibitors, monoclonal antibodies, and gene therapy, are being investigated for otologic applications.
- These therapies show potential for regenerating damaged auditory structures and restoring hearing.
- Further research is needed to translate these findings into clinical practice.
Conclusions:
- Biologic therapies have the potential to revolutionize hearing loss management.
- Clinicians should stay informed about advancements in this field.
- Future research should focus on clinical translation and therapeutic efficacy.
More Related Videos
09:07Author Spotlight: Advancing Endoscopic Ossiculoplasty – Techniques, Innovations, and Practical Guidance for Clinical Integration
Published on: January 26, 2024
06:55A Surgical Procedure for the Administration of Drugs to the Inner Ear in a Non-Human Primate Common Marmoset Callithrix jacchus
Published on: February 27, 2018
Related Concept Videos
Drug Products: Biologics, Biosimilars and Interchangeables
Microorganisms in Medicine and Therapeutics
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Biopharmaceutics and Pharmacokinetics: Overview
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF